In Silico Simulation of Corticosteroids Effect on an NFkB- Dependent Physicochemical Model of Systemic Inflammation

BACKGROUND During the onset of an inflammatory response signaling pathways are activated for "translating" extracellular signals into intracellular responses converging to the activation of nuclear factor (NF)-kB, a central transcription factor in driving the inflammatory response. An inadequate control of its transcriptional activity is associated with the culmination of a hyper-inflammatory response making it a desired therapeutic target. Predicated upon the nature of the response, a systems level analysis might provide rational leads for the development of strategies that promote the resolution of the response. METHODOLOGY AND FINDINGS A physicochemical host response model is proposed to integrate biological information in the form of kinetic rules and signaling cascades with pharmacokinetic models of drug action for the modulation of the response. The unifying hypothesis is that the response is triggered by the activation of the NFkB signaling module and corticosteroids serve as a template for assessing anti-inflammatory strategies. The proposed in silico model is evaluated through its ability to predict and modulate uncontrolled responses. The pre-exposure of the system to hypercortisolemia, i.e. 6 hr before or simultaneously with the infectious challenge "reprograms" the dynamics of the host towards a balanced inflammatory response. However, if such an intervention occurs long before the inflammatory insult a symptomatic effect is observed instead of a protective relief while a steroid infusion after inducing inflammation requires much higher drug doses. CONCLUSIONS AND SIGNIFICANCE We propose a reversed engineered inflammation model that seeks to describe how the system responds to a multitude of external signals. Timing of intervention and dosage regimes appears to be key determinants for the protective or symptomatic effect of exogenous corticosteroids. Such results lie in qualitative agreement with in vivo human studies exposed both to LPS and corticosteroids under various time intervals thus improving our understanding of how interacting modules generate a behavior.

[1]  Panagiota T. Foteinou,et al.  An indirect response model of endotoxin-induced systemic inflammation , 2007 .

[2]  Young Sang Kim,et al.  Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins. , 2007, Molecules and cells.

[3]  Chien-Chang Lee,et al.  Comparison of clinical manifestations and outcome of community-acquired bloodstream infections among the oldest old, elderly, and adult patients. , 2007 .

[4]  Richard R. Almon,et al.  Third-generation model for corticosteroid pharmacodynamics: Roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver , 1995, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[6]  David J Klinke,et al.  Modulating temporal control of NF-kappaB activation: implications for therapeutic and assay selection. , 2008, Biophysical journal.

[7]  S. Calvano,et al.  Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. , 1993, Journal of immunology.

[8]  Gilles Clermont,et al.  A MATHEMATICAL SIMULATION OF THE INFLAMMATORY RESPONSE TO ANTHRAX INFECTION , 2008, Shock.

[9]  C. Galanos,et al.  Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.

[10]  J. Rubin,et al.  In Silico and In Vivo Approach to Elucidate the Inflammatory Complexity of CD14-deficient Mice , 2006, Molecular medicine.

[11]  John D. Storey,et al.  Significance analysis of time course microarray experiments. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Sprung,et al.  High-dose corticosteroids in patients with the adult respiratory distress syndrome. , 1987, The New England journal of medicine.

[13]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[14]  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[15]  K. Tracey,et al.  Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. , 1989, Annals of surgery.

[16]  M. Meisner,et al.  Modulation of mouse endotoxin shock by inhibition of phosphatidylcholine-specific phospholipase C. , 1998, The Journal of pharmacology and experimental therapeutics.

[17]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.

[18]  M. Karin,et al.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.

[19]  Shuzhong Zhang,et al.  Pharmacodynamics and Pharmacogenomics of Diverse Receptor-Mediated Effects of Methylprednisolone in Rats Using Microarray Analysis , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[20]  Meindert Danhof,et al.  Disease System Analysis: Basic Disease Progression Models in Degenerative Disease , 2005, Pharmaceutical Research.

[21]  D. Rifkind Prevention by polymyxin B of endotoxin lethality in mice , 1967, Journal of bacteriology.

[22]  U. Senftleben NF-kappaB in critical diseases: a bad guy? , 2003, Intensive care medicine.

[23]  David S. Broomhead,et al.  Sensitivity analysis of parameters controlling oscillatory signalling in the NF-/sub K/Bpathway: the roles of IKK and I/sub K/B/sub alpha/ , 2004 .

[24]  J. Briegel,et al.  Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses. , 2001, Journal of the American Society of Nephrology : JASN.

[25]  Gilles Clermont,et al.  IN SILICO MODELS OF ACUTE INFLAMMATION IN ANIMALS , 2006, Shock.

[26]  Mehmet Toner,et al.  Application of genome-wide expression analysis to human health and disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[28]  Djillali Annane,et al.  Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis , 2004, BMJ : British Medical Journal.

[29]  Jin Y. Jin,et al.  Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series , 2005, The AAPS Journal.

[30]  Richard R. Almon,et al.  Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[31]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[32]  T. Iwaya,et al.  Randomized Study of the Benefits of Preoperative Corticosteroid Administration on the Postoperative Morbidity and Cytokine Response in Patients Undergoing Surgery for Esophageal Cancer , 2002, Annals of surgery.

[33]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[34]  P. Nyström,et al.  The systemic inflammatory response syndrome: definitions and aetiology. , 1998, The Journal of antimicrobial chemotherapy.

[35]  D. Broomhead,et al.  Sensitivity analysis of parameters controlling oscillatory signalling in the NF-kappaB pathway: the roles of IKK and IkappaBalpha. , 2004, Systems biology.

[36]  Yaniv Almog,et al.  Corticosteroids in sepsis: a new concept for an old drug. , 2003, The Israel Medical Association journal : IMAJ.

[37]  Jin Y. Jin,et al.  Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays , 2003, Journal of Pharmacology and Experimental Therapeutics.

[38]  G. Meduri,et al.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. , 1998, JAMA.

[39]  William J Jusko,et al.  Diversity of mechanism-based pharmacodynamic models. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[40]  R. Carmody,et al.  Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. , 2007, Cellular & molecular immunology.

[41]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[42]  W. Jusko Receptor-mediated pharmacodynamics of corticosteroids. , 1994, Progress in clinical and biological research.

[43]  U. Senftleben NF-κB in critical diseases: a bad guy? , 2003, Intensive Care Medicine.

[44]  G. Clermont,et al.  In silico design of clinical trials: A method coming of age , 2004, Critical care medicine.

[45]  Debra C DuBois,et al.  A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens. , 2007, Endocrinology.

[46]  D. DuBois,et al.  Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[47]  R. Lefering,et al.  Steroid controversy in sepsis and septic shock: a meta-analysis. , 1995, Critical care medicine.

[48]  J. Rubin,et al.  A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. , 2006, Journal of theoretical biology.

[49]  Nigel Mackman,et al.  Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C , 2007, The Journal of experimental medicine.

[50]  Debra C DuBois,et al.  Corticosteroid-regulated genes in rat kidney: mining time series array data. , 2005, American journal of physiology. Endocrinology and metabolism.

[51]  D. Annane,et al.  Corticosteroids for treating severe sepsis and septic shock. , 2004, The Cochrane database of systematic reviews.

[52]  F. Holsboer,et al.  Glucocorticoids suppress interleukin-1 receptor antagonist synthesis following induction by endotoxin. , 1994, Endocrinology.

[53]  Gary An,et al.  Translational Systems Biology of Inflammation , 2008, PLoS Comput. Biol..

[54]  Kim Sneppen,et al.  Minimal model of spiky oscillations in NF-kappaB signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Hawn,et al.  Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages , 2008, International journal of medical sciences.

[56]  C Ronco,et al.  Recent insights into the pathogenesis of severe sepsis. , 2005, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[57]  Ioannis P. Androulakis,et al.  Bioinformatics analysis of the early inflammatory response in a rat thermal injury model , 2007, BMC Bioinformatics.

[58]  D. Lauffenburger,et al.  Analysis of a lumped model for tissue inflammation dynamics. , 1981, Mathematical biosciences.

[59]  Panagiota T. Foteinou,et al.  Modeling endotoxin-induced systemic inflammation using an indirect response approach. , 2009, Mathematical biosciences.

[60]  D. Hume,et al.  Inflammation suppressor genes: please switch out all the lights , 2005, Journal of leukocyte biology.

[61]  G. Clermont,et al.  THE ACUTE INFLAMMATORY RESPONSE IN DIVERSE SHOCK STATES , 2005, Shock.

[62]  W. Jusko,et al.  Mathematical Formalism for the Properties of Four Basic Models of Indirect Pharmacodynamic Responses , 1997, Journal of pharmacokinetics and biopharmaceutics.

[63]  J. Dean,et al.  Control of the expression of inflammatory response genes. , 2003, Biochemical Society symposium.

[64]  M. Abreu,et al.  TLR4 and MD-2 Expression Is Regulated by Immune-mediated Signals in Human Intestinal Epithelial Cells* , 2002, The Journal of Biological Chemistry.

[65]  Ryan Zurakowski,et al.  A model predictive control based scheduling method for HIV therapy. , 2006, Journal of theoretical biology.

[66]  R. Ramakrishnan,et al.  Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[67]  Peter A. Ward,et al.  Novel strategies for the treatment of sepsis , 2003, Nature Medicine.

[68]  K. Sneppen,et al.  Minimal model of spiky oscillations in NF-κB signaling , 2006 .

[69]  J. Marshall,et al.  Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence , 2002, Critical care.

[70]  G. Clermont,et al.  The dynamics of acute inflammation. , 2004, Journal of theoretical biology.

[71]  J. Marshall,et al.  Let the Cells Speak: Neutrophils as Biologic Markers of the Inflammatory Response , 1998, Sepsis.

[72]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[73]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[74]  J. Rubin,et al.  A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration. , 2006, Journal of theoretical biology.

[75]  S. Calvano,et al.  In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin , 1992, Infection and immunity.

[76]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[77]  A. Aderem,et al.  A systems approach to dissecting immunity and inflammation. , 2004, Seminars in immunology.

[78]  H. Volk,et al.  Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. , 2003, American journal of respiratory and critical care medicine.

[79]  T. van der Poll,et al.  Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[80]  A. Baldwin,et al.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.

[81]  J. Briegel,et al.  A new role for glucocorticoids in septic shock: balancing the immune response. , 2003, American journal of respiratory and critical care medicine.

[82]  Panagiota T. Foteinou,et al.  Translational Potential of Systems‐Based Models of Inflammation , 2009, Clinical and translational science.